AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
22,322,586
Share change
-715,439
Total reported value
$314,081,000
Put/Call ratio
1.4%
Price per share
$14.07
Number of holders
40
Value change
-$10,424,555
Number of buys
20
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q2 2017

As of 30 Jun 2017, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,322,586 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, BlackRock Inc., FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Boxer Capital, LLC, Ghost Tree Capital, LLC, VANGUARD GROUP INC, and Alyeska Investment Group, L.P.. This page lists 40 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.